Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 59Active not recruiting 37Completed 20Not yet recruiting 6Terminated 3Suspended 3Available 2No longer available 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 127Breast Neoplasms 110Neoplasms 95Neoplasm Metastasis 78Melanoma 71Leukemia, Myeloid, Acute 68Colorectal Neoplasms 67Prostatic Neoplasms 59Ovarian Neoplasms 51Multiple Myeloma 51Lung Neoplasms 50Squamous Cell Carcinoma of Head and Neck 47Triple Negative Breast Neoplasms 42Recurrence 42Carcinoma, Renal Cell 40Carcinoma, Hepatocellular 39Myelodysplastic Syndromes 35Pancreatic Neoplasms 34Glioblastoma 34Brain Neoplasms 31Stomach Neoplasms 30Lymphoma 30Lymphoma, Non-Hodgkin 28Lymphoma, Large B-Cell, Diffuse 28Leukemia 28Head and Neck Neoplasms 28Endometrial Neoplasms 28Uterine Cervical Neoplasms 26Cholangiocarcinoma 26Urinary Bladder Neoplasms 24

Interventions

niraparib 1dostarlimab 1cabozantinib 1Tablets 1Suspensions 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Osteosarcoma × 1 year × Clear all
NCT06341712 2026-03-31

CabOSTar

Ipsen

Phase 2 Terminated
10 enrolled
Sarcoma

Osteosarcoma

NCT04544995 2026-01-21

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

GlaxoSmithKline

Phase 1 Terminated
47 enrolled 43 charts
CNSSarcoma

Neoplasms, Neuroblastoma, Osteosarcoma

NCT06438783 2025-12-12

TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Terminated
20 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡